PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Infectious Diseases, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.\', \'Department of Medicine, Division of Infectious Diseases, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.\', \'Infectious Diseases Department, Fakeeh Care, Jeddah, Saudi Arabia.\', \'Department of Medicine, Division of Infectious Diseases, King Abdulaziz Specialist Hospital, Taif, Saudi Arabia.\', \'Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.\', \'Infection Control Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.\', \'College of Medicine, AlFaisal University, Riyadh, Saudi Arabia.\', \'Research Center, Almoosa Specialist Hospital, Al-ahsa, Saudi Arabia.\', \'College of Nursing, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.\', \'School of Nursing, University of Wollongong, Wollongong, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/iid3.587
?:hasPublicationType
?:journal
  • Immunity, inflammation and disease
is ?:pmid of
?:pmid
?:pmid
  • 35029324
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • 3
is ?:relation_isRelatedTo_publication of
?:title
  • Early use of tocilizumab in solid organ transplant recipients with COVID-19: A retrospective cohort study in Saudi Arabia.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all